Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aristi Boulmpou

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Acta Cardiologica|September 19, 2023
Prompting ChatGPT to perform an umbrella reviewEleftherios Teperikidis, Aristi Boulmpou, Christodoulos Papadopoulos
Diabetes, Obesity & Metabolism|February 19, 2021
Meta-analysis of the hallmark cardiovascular and renal outcome trials addressing the risk for respiratory tract infections with sodium-glucose co-transporter-2 inhibitors: Implications for the COVID-19 pandemicDimitrios Patoulias, Christodoulos Papadopoulos, Aristi Boulmpou, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 29, 2022
Another brick in the wall of cardioprotection? A meta-analysis addressing the effect of sodium-glucose co-transporter 2 inhibitors on left ventricular mass assessed by cardiovascular magnetic resonance in patients with heart failure with reduced ejection fractionDimitrios Patoulias, Aristi Boulmpou, Michael Doumas, et al.
Kidney Medicine|August 17, 2021
Glucagon-like Peptide-1 Receptor Agonists and the Risk of Acute Kidney Injury: Alarming, or Not?Dimitrios Patoulias, Aristi Boulmpou, Christodoulos E Papadopoulos, et al.
Minerva Cardiology and Angiology|July 26, 2024
Using ChatGPT to perform a systematic review: a tutorialLefteris Teperikidis, Aristi Boulmpou, Christodoulos Papadopoulos, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 18, 2025
"Less Metal" in a Complex Left Main Trifurcation LesionGeorgios Zormpas, Aristi Boulmpou, Christodoulos E Papadopoulos, et al.
Acta Cardiologica|June 14, 2022
Meta-analysis of cardiovascular outcome trials assessing the impact of glucagon-like peptide-1 receptor agonists on major cardiac arrhythmiasAristi Boulmpou, Dimitrios Patoulias, Christodoulos E Papadopoulos, et al.
Journal of Diabetes and Metabolic Disorders|June 8, 2022
Net benefit regarding the risk for death with sodium-glucose co-transporter-2 inhibitors across the hallmark cardiovascular and renal outcome trials; are there any drug differences?Dimitrios Patoulias, Christodoulos Papadopoulos, Aristi Boulmpou, et al.
Polish Archives of Internal Medicine|March 30, 2021
The obesity pandemic among patients with coronary artery disease: do we have enough to tackle its progression?Dimitrios Patoulias, Fotios Siskos, Aristi Boulmpou, et al.
European Journal of Internal Medicine|November 29, 2024
Validating ChatGPT's role in systematic reviews and meta-analyses: A case study on GLP-1 receptor agonists and all-cause mortalityLefteris Teperikidis, Paschalis Karakasis, Dimitrios Patoulias, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Acta Cardiologica|September 19, 2023
Prompting ChatGPT to perform an umbrella reviewEleftherios Teperikidis, Aristi Boulmpou, Christodoulos Papadopoulos
Diabetes, Obesity & Metabolism|February 19, 2021
Meta-analysis of the hallmark cardiovascular and renal outcome trials addressing the risk for respiratory tract infections with sodium-glucose co-transporter-2 inhibitors: Implications for the COVID-19 pandemicDimitrios Patoulias, Christodoulos Papadopoulos, Aristi Boulmpou, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 29, 2022
Another brick in the wall of cardioprotection? A meta-analysis addressing the effect of sodium-glucose co-transporter 2 inhibitors on left ventricular mass assessed by cardiovascular magnetic resonance in patients with heart failure with reduced ejection fractionDimitrios Patoulias, Aristi Boulmpou, Michael Doumas, et al.
Kidney Medicine|August 17, 2021
Glucagon-like Peptide-1 Receptor Agonists and the Risk of Acute Kidney Injury: Alarming, or Not?Dimitrios Patoulias, Aristi Boulmpou, Christodoulos E Papadopoulos, et al.
Minerva Cardiology and Angiology|July 26, 2024
Using ChatGPT to perform a systematic review: a tutorialLefteris Teperikidis, Aristi Boulmpou, Christodoulos Papadopoulos, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 18, 2025
"Less Metal" in a Complex Left Main Trifurcation LesionGeorgios Zormpas, Aristi Boulmpou, Christodoulos E Papadopoulos, et al.
Acta Cardiologica|June 14, 2022
Meta-analysis of cardiovascular outcome trials assessing the impact of glucagon-like peptide-1 receptor agonists on major cardiac arrhythmiasAristi Boulmpou, Dimitrios Patoulias, Christodoulos E Papadopoulos, et al.
Journal of Diabetes and Metabolic Disorders|June 8, 2022
Net benefit regarding the risk for death with sodium-glucose co-transporter-2 inhibitors across the hallmark cardiovascular and renal outcome trials; are there any drug differences?Dimitrios Patoulias, Christodoulos Papadopoulos, Aristi Boulmpou, et al.
Polish Archives of Internal Medicine|March 30, 2021
The obesity pandemic among patients with coronary artery disease: do we have enough to tackle its progression?Dimitrios Patoulias, Fotios Siskos, Aristi Boulmpou, et al.
European Journal of Internal Medicine|November 29, 2024
Validating ChatGPT's role in systematic reviews and meta-analyses: A case study on GLP-1 receptor agonists and all-cause mortalityLefteris Teperikidis, Paschalis Karakasis, Dimitrios Patoulias, et al.
Pageof 6